trial · primary record
ziftomenib
Gastrointestinal Stromal Tumor (GIST)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 135 |
| Primary completion | 2030-06 |
| Primary endpoint | Dose Limiting Toxicity (DLT) (Dose Expansion) |
| Registry ID | NCT06655246 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:07.328Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06655246
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.